Moberg Pharma acquires three OTC brands from Bayer HealthCare

On December 6, 2013, Moberg Pharma (STO:MOB) announced the acquisition of three Over-The-Counter brands in the U.S. from Bayer HealthCare, LLC. The acquisition has now been completed. The purchase price amounted to 4.8 MUSD.

The acquired portfolio includes Domeboro®, a topical astringent used for relieving itch and minor skin irritations; Vanquish®, an internal analgesic; and Fergon®, an iron supplement. The brands are sold through Moberg's current channel, primarily in chain drugstores and mass retailers, such as Walmart.